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Abstract
Social media is a relatively new form of media that includes social networks for communication 
dissemination and interaction. Patients, physicians, and other users are active on social media 
including the microblogging platform Twitter. Many online resources are available to facilitate 
joining and adding to online conversations. Social media can be used for professional uses, 
therefore we include anecdotes of physicians starting on and implementing social media 
successfully despite the limits of time in busy practices. Various applications demonstrating the 
utility of social media are explored. These include case discussions, patient groups, research 
collaborations, medical education and crowdsourcing/crowdfunding. Social media is integrating 
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into the professional workflow for some individuals and hematology/oncology societies. The 
potential for improving hematology care and research is just starting to be explored.
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What is social media?
Social media is a form of media.1 Media is used to communicate. Communication is at the 
core of what we do – with patients, with colleagues and with the public. The use of social 
media in hematology seemed to substantially increase at the American Society of 
Hematology (ASH) 2014 (#ASH14) meeting as well as at the 2015 Annual BMT Tandem 
Meetings (#BMTTandem15) and 41st Annual Meeting of the European Society for Blood 
and Marrow Transplantation (#EBMT15). Describing social media in a manuscript can be 
similar to giving a didactic lecture on “how to ride a bike;” that is, it is far easier and more 
fun to do the activity than explain or read about the mechanisms. To ease into the more 
esoteric aspects, the authors will first describe briefly how we became interested in social 
media and the role social media is playing for hematology. While social media is media,1 
there are differences between social versus traditional media. Social media is faster, 
permanent (archived), interactive and searchable, and its impact often amplifies beyond the 
initial “broadcast” audience. There are many plaforms on social media, a few will be 
reviewed here with emphasis on Twitter.
How the authors got started in social media
Navneet Majhail, MD, MS (@BldCancerDoc) was “toying about” with social media and 
“took the plunge” before the American Society of Hematology (ASH) 2014 Annual 
Meeting. His blog post, "@BldCancerDoc, Or How I Learned to Stop Worrying and Love 
Twitter," describes how he became hooked.2 He also wrote about his dual role of in real life 
and digital presence on Twitter in the European Group for Blood and Marrow 
Transplantation (EBMT) newsletter.3 One of many quotable notes: “If you can take care of 
transplant patients, you can easily use Twitter!”
Miguel Perales, MD (@DrMiguelPerales), a medical oncologist who specializes in stem cell 
transplantation, joined Twitter about 2 years ago, inspired by one of his colleagues, Anas 
Younes, MD (@DrAnasYounes). By following several colleagues active in social media, 
including Robert Miller, MD (@rsm2800), and Michael Thompson, MD, PhD 
(@mtmdphd), Dr. Perales uses the platform to stay up to date, share information, and 
interact with colleagues and others. He has led efforts to enhance the Twitter presence of the 
American Society for Blood and Marrow Transplantation (@ASBMT) and the Blood and 
Marrow Transplantation Clinical Trials Network (@BMTCTN),and also chairs the Sub-
Committee on Web-Based Learning of the ASBMT and the Digital Education Working 
Group of ASH.
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Dr. Thompson (@mtmdphd) first got involved with social media when Michael Fisch, MD, 
MPH (@fischmd), gave a talk on the subject at the MDACC Community Clinical Oncology 
Program (CCOP) Annual Meeting in Houston after the “Arab Spring” uprisings in the 
Middle East in 2011. Dr. Fisch then mentored him on using Twitter, and the two have since 
shared ideas on the use of social media. Dr. Thompson’s first “Tweetup” was at the 
American Society of Clinical Oncology (ASCO) 2011 meeting, where he met other 
interested “tweeps” (i.e. Twitter users) and started increasing his social media interactions 
and presence, eventually joining the ASCO Integrated Media and Technology Committee 
and working with ASCO staff on ASCO Connection blogs. After hearing from visionaries 
such as Dave deBronkart (@ePatientDave) and Wendy Sue Swanson, MD 
(@SeattleMamaDoc), at the Mayo/Ragan Social Media Conference in October 2011, he 
started interacting more, an example of which occurred at the ASCO 2012 Annual Meeting 
where he and early Twitter users Drs. Younes and Miller discussed the topic, “Using Social 
Media in Oncology for Education and Patient Engagement.”4
William Wood, MD, MPH (@WoodBD) is an Assistant Professor at the University of North 
Carolina in the division of hematology/oncology. For several years he has written a column 
for HemOnc Today, and through that experience learned the benefits of using a medium of 
informal conversation to connect with individuals from many different backgrounds about 
topics relevant to his clinical practice and research. He later discovered that Twitter has the 
same capabilities, except in a mode that involves shorter pieces of information at a time, a 
wider audience and a robust, almost real-time back-and-forth discussion. He has found that 
information learned and shared on Twitter is very relevant to his academic life, making it a 
useful source of continuous learning and a helpful way to make connections with others. His 
experience with online clinical case sharing has several parallels to traditional and social 
media platforms. Online clinical case sharing platforms allow him to engage in rapid and 
robust exchange of ideas, and to learn from others with different backgrounds and 
perspectives than his own.
Anatomy of a Tweet and Twitter 101
Anatomy of a Tweet
Twitter is a microblogging social media tool that is optimized for use on a mobile platform 
(e.g., iOS or Android), although it can be easily accessed through a desktop computer 
device. The application is fairly intuitive and has a minimalist interface. Figure 1 shows the 
typical steps involved in composing a “tweet,” which cannot exceed 140 characters 
(including spaces). Followers of the individual composing the message can view and 
“retweet” or “favorite” the tweet, which in turn can be retweeted or favorited by their 
followers, and so on – giving the opportunity for the original tweet to receive wide and 
quick dissemination through several “impressions” (similar to signal transduction 
amplification in biology).
The components of a tweet are shown in Figure 2. Given the limited number of characters 
allowed, acronyms and emoticons are frequently used and grammar may need to be 
compromised to convey your message. “Hashtags” (e.g., #cancer, #ASCO15, #bmtsm) are 
used to identify specific terms and facilitate search and curation of information. One 
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oncology hashtag organization scheme is the “Cancer Tag Ontology (CTO)” developed by 
Matthew Katz, MD (@subatomicdoc), and colleagues.5 Other Twitter users can be 
identified by the “@” symbol or their Twitter “handle” (e.g., @BldCancerDoc, @mtmdphd, 
@Mohty_EBMT). If an internet link is included, Twitter can automatically shorten it in 
order to save characters. Alternatively, another website (e.g., goo.gl, bitly,com, tinyurl.com, 
ow.ly) can be used to shorten the link. By using sites such as these, users can archive links 
and also obtain metrics and the number of users who accessed a link through the original 
poster. This is another way you can measure the impact of tweets. Tweets can include 
website thumbnails, photographs and/or videos. Common abbreviations that may 
accompany a tweet include RT (retweet – when a follower re-posts a tweet on his/her own 
profile), MT (modified tweet – when a follower alters a tweet before posting it on his/her 
profile) and HT (hat tip/heard through – when a follower acknowledges the source and 
includes the Twitter identification of the original composer of the tweet).
Twitter 101
As Dr. Bryan Vartabedian (@Doctor_V) noted in his blog 33 Charts: “While newbie public 
physicians need to be educated, there are great resources available…”.6 A few helpful 
references7-18 for getting started are provided in Table 1.
Additional contextual commentary is provided in “Social Media Starter Kit and Managing 
Your Digital Reputation”19 by Drs. Jeffrey Geske and Farris Timimi.
Twitter for Professional Use
Dr. Vartabedian also remarked: “We’ve reached a point where social media is now part of 
the professional workflow.”6 There is an ever increasing menu of social medial platforms 
available today. However, Twitter has some advantages that make it preferable for 
professional use among health care providers. The interface of the mobile application is 
intuitive and simple to use, information is presented in smaller bites and can be processed 
quickly, it offers greater control over content, and it allows for rapid dissemination of 
information. Twitter gives users flexibility in determining their level of participation, which 
can range from being a passive consumer to the other end of the spectrum where an 
individual can be an active creator of content.
Some examples of how Twitter can be used for professional purposes include:
– Obtaining information on latest research: Most major medical journals have a Twitter 
presence and routinely post information on release of new issues, prepublished articles 
and other related content such as blogs. Journals may have their own Twitter username 
(e.g., @NEJM, @TheLancet, @nature) or they may post under the Twitter username of 
the parent professional society (e.g., @ASCO, @ASH_hematology). Hashtags may also 
be used to identify articles published by specific journals (e.g., #bloodjournal, #JCO). In 
addition, several non-peer reviewed journals/medical news periodicals share 
information and content on Twitter (e.g., @ASCOPost, @ASHClinicalNews, 
@HemOncToday).
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– Obtaining information relevant to the profession: Professional health care 
organizations largely have Twitter accounts, which are used to disseminate information 
about educational opportunities, practice, policy, advocacy and professional news. 
Organizations may have more than one Twitter account to highlight different aspects of 
their mission and work (e.g., @ASH_hematology and @ASHClinicalNews, @ASCO 
and @ASCOPost).
– Following key opinion leaders and experts: Many experts in several areas of 
hematology and oncology are prolific tweeters. By following them, one can get their 
opinion on a variety of topics, such as their own research and the work of their peers, as 
well as recently published papers. Twitter also allows the opportunity to have a 
discourse on health care- related topics.
– Sharing research findings and publications: Twitter provides a forum for 
dissemination of information on an individual’s research and publications. Similarly, 
one can share information on research and papers from peers and colleagues that is 
interesting or cutting- edge. Twitter has been used to identify and establish research 
collaborations as well. Whether promoting a paper on Twitter impacts its citations is 
debatable, and highly tweeted publications likely represent research that would be 
highly cited regardless of social media use.20-22 @BMTCTN is currently promoting the 
52 publications of the network to date by tweeting them in chronological order one 
paper/week every Thursday (#TBT = throw back Thursday).
– Learning opportunities: Several professional organizations announce educational 
offerings through Twitter. This social media platform also can be used to “virtually 
attend” a medical conference (see use cases below). There are Twitter chats and Twitter 
journal clubs focused around health care topics.
– Receive patient feedback: Many patients and patient advocacy organizations have a 
strong Twitter presence. They can provide a unique patient-centered perspective on 
their experience with the health care system, what is relevant to them and the latest 
research in their area of interest.
– Follow nonmedical interests: One can use Twitter to follow other areas of interest 
(e.g., news, sports) that can provide a quick and needed distraction from the daily 
physical and mental stress of working as a health care provider.
Application of Social Media in Hematology
Another insight provided by Dr. Vartabedian was: “At some point we must go beyond the 
introduction and into application.”6 Sample case studies that highlight the direct application 
of social media in hematology practice are presented in this section.
Social media to facilitate clinical case discussions
The American Society of Blood and Marrow Transplantation (ASBMT) partnered with Best 
Doctors (Quincy, MA) to launch the Clinical Case Forum (ASBMT-CCF) using the Medting 
platform (medting.com) in February 2014. The CCF provides a secure online forum for the 
discussion of challenging clinical care issues within the field of hematopoietic stem cell 
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transplantation. The CCF has a user-friendly interface, which allows users to post 
information about cases, including attachments with images (radiology, pathology, etc.), and 
others to comment on the case. Cases are organized primarily in disease-specific categories 
and include key words to allow for search functionality. As of December 2014, a total of 
120 cases had been posted, and cases received a total of 474 comments. Cases and 
comments were posted by 54 and 88 individual users, respectively. The CCF has facilitated 
engaged discussions, which have resulted in knowledge sharing among a broad group of 
users. In particular, the CCF has seen robust international participation, with several cases 
posted from countries with lower transplant team density. Examples of countries represented 
include Argentina, Chile, Peru, India, Jordan, Mexico, Slovenia and Turkey, among others. 
Thus, the ASBMT-CCF is addressing an area of need for the international community. 
Furthermore, some centers are using the cases for teaching purposes and a manuscript is 
being prepared as a case discussion based on one of the interesting cases posted. Another 
manuscript will include a complete analysis of the cases posted and identification of unmet 
needs in the field of hematopoietic stem cell transplantation. Finally, in a number of cases, 
the recommendations have resulted in a direct impact on the clinical care of patients. The 
success of the ASBMT-CCF can serve as model for other professional societies or medical 
specialties to foster online case-based collaboration and knowledge sharing.
Facebook Patient Groups
Myeloma patient Dana Holmes, in a post within a Facebook forum she created titled 
“Asymptomatic ‘Smoldering’ Multiple Myeloma ‘aka’-SMM - Information Exchange,”23 
wrote:
“I ‘met’ Michael Lalli in one of the MM FB support groups… he has been 
smoldering for about 3 years, relatively stable, quarterly labs and has recently 
begun to experience severe lower back pain and extreme fatigue. He had not yet 
had any advanced imaging diagnostics w/ his oncologist.
I shared the transcript to the recent Twitter chat hosted by Mike Thompson with 
Michael Lalli. The chat featured Dr. Morie Gertz from the Mayo Clinic. The topic 
was the role of imaging in MGUS and SMM and it is an excellent resource to now 
share w/ smoldering patients so they can begin to understand the changes being 
supported by the top myeloma specialists.
Here is a link to the paper Dr. Gertz authored, published in JCO in January 2015 
[titled “Advanced Skeletal Imaging Redefines the Management of Plasma Cell 
Disorders”].
So, what is the moral to my story? Michael brought this information to his 
oncologist this past Wednesday and shared it with him. Michael is having a 
PET/CT today which will help him get some answers to the current status of his 
disease state.
So members, print out this info and share it with your own oncologists at your next 
appointment, it doesn't hurt to be sure they are up to date on the current 
recommendations. Be a partner in your care.”
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Holmes noted how patient forums can amplify other social media sources, such as Twitter, 
with references to primary literature. This educates savvy patients and can change actual 
care. Patients become less passive and more emotionally empowered. These participatory 
patients have been called e-patients for: Empowered, Engaged, Equipped and Enabled.24
Curating information
The multiple myeloma social media (#mmsm) Twitter discussion Dana Holmes was 
referring to occurred on July 1, 2015, and is available at http://ow.ly/P5zW1. The creation of 
the #mmsm hashtag with patient Cynthia Chmielewski (@myelomateacher) has been 
previously discussed.25 Since the first organized #mmsm Twitter discussion with Drs. 
Vincent Rajkumar (@VincentRK) and Robert Orlowski (@Myeloma_Doc) in September 
2013, almost 20 chats have occurred and the hashtag has been used to tag multiple 
myeloma-specific content of interest at and between national meetings. In an analysis by 
Reid and colleagues, physician conversations about multiple myeloma on Twitter more than 
quadrupled between 2012 and 2013 in a background of physician tweets about cancer 
growing by 20% during 2013.26,27
On January 10, 2015, Naveen Pemmaraju, MD (@doctorpemm), created the 
myeloproliferative neoplasms social media (#mpnsm) hashtag based on the example of 
#mmsm. He had previously joined Twitter just before the American Association for Cancer 
Research (AACR) 2014 meeting. At the ASH 2014 meeting there was no yet established 
meeting place on Twitter for academic clinician/researchers interested in myeloproliferative 
neoplasms (MPNs). Implementation of this hashtag led to sharing educational information, 
research collaborations and a tweet chat. Building on these successes, Dr. Thompson created 
the Waldenström macroglobulinemia social media (#wmsm) hashtag in June 2015. Other 
cancer and hematology hashtags will continue to evolve. These rare disease discussion 
venues may be particularly important for both patients, researchers and clinicians as these 
are uncommon even at tertiary centers.
The @ASBMT Online Journal Club (@bmtojc) was launched in 2014 by Andreas Klein, 
MD (@AndreasKlein MD), Dr. Perales and Dr. Wood. The journal club is held quarterly for 
fellows on a Google hangout with live-streaming and archiving on YouTube and 
simultaneous discussion on Twitter. The article is presented by a fellow and a faculty 
discussant (often one of the lead authors of the article being discussed). This is another 
example of social media being used for medical education (#MedEd).
Crowdsourcing and crowdfunding
The Myeloma Crowd Research Initiative (#MCRI, @myelomacrowd) is a new approach to 
funding cancer research. It combines expert opinion leaders in medical oncology with 
patient and advocate perspectives and is utilizing supportive patient social communities to 
select and fund promising research projects in myeloma. The goal of the MCRI is to review 
and select specific myeloma projects to fund via crowdfunding. More information is 
available at http://www.myelomacrowd.org/mcri/. Crowdfunding cancer research and 
helping take care of patients is similar in some ways to the Medting concept and has been 
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covered by Lola Butcher in Oncology Times.28 This mechanism is currently working for 
MCRI and ongoing fundraising is currently in process.
Leveraging social media at medical conferences
Use of social media increased conspicuously at the ASH 2014 Annual Meeting (#ASH14). 
As noted before, this enthusiasm was caught in the blog post “@BldCancerDoc, Or How I 
Learned to Stop Worrying and Love Twitter."2 Analytics from Symplur can be used to 
analyze various time frames for #ASH14 via http://www.symplur.com/healthcare-hashtags/
ash14/. Over the duration of the meeting only (pre/post meeting duration increases numbers) 
the following analytics were for 2013/2014: impressions 17,992,383/49,624,330; tweets: 
7426/16,433; users who tweet: 1,236/2,876.
According to Greg Matthews (@Chimoose) of the W2O Group, physician conversations 
increased 44% from #ASH14 to #ASH13, and the number of physicians tweeting increased 
83% (133 to 243). His social net analysis from #ASH13 is available at http://bit.ly/
ASH13mdsna. The corresponding #ASH14 network map is available at http://bit.ly/
ASH14mdsna. Ekins and Perlstein have suggested “Ten Simple Rules of Live Tweeting at 
Scientific Conferences.”29 Implementation of such suggestions may improve the network 
map quality – that is, more diverse connections between users.
The EBMT gathers more than 500 transplant centers in and outside Europe. It has made a 
big step forward these past two years by integrating social media into its overall strategy. 
EBMT created its Twitter profile, @TheEBMT, and is now engaging with several hundred 
followers (and growing). The objective is to increase this number to engage more 
participants and create a large group of tweeps who can generate, share and refine new ideas 
in the field of hematology. Every year, EBMT organizes its annual meeting of more than 
4,000 participants, including scientists, physicians, nurses, statisticians, data managers, 
biologists, technicians and patients. This major forum in the field is an important moment to 
ensure and encourage exchange, education and scientific productivity. For the first time in 
2015, EBMT engaged with its audience through Twitter, with the main objective to amplify 
the dissemination and discussion of scientific knowledge. Twitter has benefited the scientific 
community and has enabled some “virtual” participants to attend remotely. Over the four 
full days of the conference (as submitted to Symplur using Turkey time zone): 201 people 
sent 1,346 tweets using the annual meeting hashtag #EBMT15, generating 987,475 potential 
impressions. Many scientists may question the usefulness of Twitter in the distribution of 
scientific knowledge, legitimately fearing the misrepresentation of rather complex ideas. On 
the other hand, it has to be argued that although Twitter is not a science-specific platform, it 
is a powerful network that can have a long-term impact on how scientists create and publish 
ideas. The EBMT will continue to popularize the use of Twitter, especially during its annual 
meeting, as a means to amplify the scientific impact.
Conclusions
Social media is gaining traction in medicine and more recently in hematology. Online 
resources and mentors are available. Social media including Twitter isn’t that difficult – 
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even for the time- constrained – and has utility to increase education and interactions about 
hematology topics.
There are examples that demonstrate how this platform can and is being used. We no longer 
have binary stratification of “knowledge” and “no knowledge”, but rather a gradation of 
knowledge levels throughout medicine. This changes how we as health care professionals 
should interact with others including patients, the public and each other. As individuals and 
institutions, the time to engage is now.
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Composition of a tweet. Typical steps involved in composing a “tweet,” which cannot 
exceed 140 characters (including spaces).
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Anatomy of a tweet.
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Table 1
Resources for health care providers interested in Twitter
Resource Author(s) (Date)
Medicine and Social Media: Why Do I Tweet?7 Younes A (June 15, 2009)
The Evolving Role of Healthcare Professionals8 Katz MS (Oct. 20, 2011)
Practical Guidance: The Use of Social Media in Oncology15
Dizon DS, Graham D, Thompson
MA, Johnson LJ, Johnston C,
Fisch MJ, Miller R (July 17, 2012)
How Can Social Media Improve Oncology Care?16 Thompson MA (Sept. 3, 2013)
Why Do We Need Twitter? For Health Professionals in Oncology,
Hematology & SCT17
Majhail NS (March 23, 2014)
Getting Started in Social Media – What to Do Before You Join9 Katz MS (April 28, 2014)
Twitter 101: Signing Up – A Tutorial for Oncologists10 Katz MS (May 4, 2014)
Twitter 102: Account Settings – A Tutorial for Oncologists11 Katz MS (May 5, 2014)
Twitter 103: Trolls, Malware & Spam – A Tutorial for Oncologists12 Katz MS (May 5, 2014)
Internet, Social Media, Privacy Regulations, and Clinical Trials13
Bogler O, Thompson MA, Miller
RS (June 2, 2014)
Social Media & Academic Oncology – Challenges and
Opportunities14
Katz MS (Dec. 19, 2014)
"@BldCancerDoc, Or How I Learned to Stop Worrying and Love
Twitter"2
Majhail NS (March 2015)
Using Social Media to Learn and Communicate: It Is Not About
the Tweet18
Thompson MA (June 2015)
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